http://web.archive.org/web/20150513100510id_/http://www.dailymail.co.uk/health/article-2713788/BMJ-stands-claims-effects-statins-Published-papers-said-harm-good-patients-low-risk-heart-disease-not-withdrawn.html

two scientific papers which claimed statins can do more harm than good in patients with a low risk of heart disease should not be withdrawn , an investigation has found			1
the articles , published last year in the @entity8 ( @entity8 ) , caused controversy by suggesting that the benefits of the cholesterol - lowering drugs in healthier patients did not outweigh the risks of side effects			2
professor sir @entity15 , co-director of the @entity16 at @entity17 , said the papers overstated the risks of statins 20-fold , and could put lives at risk by discouraging patients from taking them			1
two scientific papers which claimed statins can do more harm than good in patients with a low risk of heart disease should not be withdrawn , an investigation has found			1
file picture but an independent panel set up by the @entity8 found there were no grounds for retraction			1
the journal did withdraw the claim that one in five people taking statins suffers side effects , but said the two papers as a whole ‘ enhanced scientific debate on a topical issue ’			0
reported side effects of the drugs include type 2 diabetes and muscular pain			0
professor @entity15 criticised the decision not to retract the papers , and said in his experience side effects are reported by less than 1 per cent of patients			0
a recent study of 27 trials , led by professor @entity15 , concluded that even low - risk patients can benefit from statins			2
this led @entity58 watchdog @entity57 to last month recommend much wider use			0
between five and ten million @entity60 currently take the drugs .			0

prof sir @entity15 , co-director of @entity16 at @entity17 , said papers overstated risks of statins 20-fold
he *added* they could put lives at risk by discouraging patients from taking them
independent panel set up by @entity8 found no grounds for retraction

@entity17:Oxford University
@entity16:Clinical Trials Research Unit
@entity15:Rory Collins
@entity8:British Medical Journal
@entity57:Nice
@entity58:NHS
@entity60:Britons